Researchers develop a cost-effective method to spatially characterize and map brain epigenomes
An estimated one in six people suffer from a brain disorder worldwide, according to the American Brain Foundation.
Regular intake of sugary drinks, fruit juices tied to higher Type 2 diabetes risk in boys
A small, long-term study of almost 500 children in Massachusetts has found that regularly drinking sugary drinks and 100% fruit juices during childhood and adolescence may be linked to a…
Study shows barriers to dementia diagnosis based on race, ethnicity, and location
Getting dementia diagnosed can be a long and difficult process for anyone, but some may face additional challenges based on race or ethnicity and where they live, according to a…
AI-based mobile app can diagnose melanoma with very high precision
A mobile app that uses artificial intelligence, AI, to analyze images of suspected skin lesions can diagnose melanoma with very high precision.
Routine genomic surveillance at antenatal care can be a cost-effective approach to detect changes in malaria transmission
Genetic diversity of the malaria parasite in pregnant women and children declined in an area targeted for malaria elimination in Mozambique, according to a study led by the Barcelona Institute…
Genetic test can identify how patients with triple negative early-stage breast cancer will respond to immunotherapy
Researchers have developed a genetic test that can identify how patients with triple negative early-stage breast cancer will respond to immunotherapy drugs.
Pembrolizumab enhances breast cancer treatment regardless of age or menopausal status
New data from the KEYNOTE-756 phase 3 clinical trial show that adding the immunotherapy drug, pembrolizumab, to chemotherapy before and after surgery for breast cancer leads to better outcomes for…
Unique bacteria colonize the gut shortly after birth and make serotonin to educate gut immune cells
A recent study revealed that neonatal gut bacteria produce serotonin and down-regulate monoamine oxidase A (MOA) to limit serotonin breakdown, thereby promoting immune tolerance.
Precision unveiled: Exploring the cutting-edge of analytical weighing with Cubis® II ultra-high resolution balances
This interview explores the cutting edge of analytical weighting with Cubis® II ultra-high resolution balances.
Nuclera joins Tech Nation’s Future Fifty program
Nuclera recognized as one of UK’s most exciting growth stage companies.